Lv1
58 积分 2024-08-22 加入
The antibody–drug conjugate targeting ROR1, NBE-002, is active in high-grade serous ovarian cancer preclinical models
1个月前
已完结
TLR-based therapeutic strategies for hepatocellular carcinoma
6个月前
已完结
Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment
7个月前
已完结
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
7个月前
已完结
Toll-Like Receptor Agonists in Cancer Therapy
7个月前
已关闭
Risk and Culture: An Essay on the Selection of Technological and Environmental Dangers
8个月前
已完结
Managing mental health service provision in the decentralized, multi-layered health and social care system of Germany
8个月前
已关闭
Risk and Culture: An Essay on the Selection of Technological and Environmental Dangers
8个月前
已完结
Revisiting a Social Constructionist Approach to Crisis Communication– Investigating Contemporary Crises in China
8个月前
已完结
Abstract LB448: VBC103: An innovative Trop2/Nectin4 targeted bispecific antibody drug conjugate (ADC) in bladder urothelial carcinoma (UC), triple-negative breast cancer (TNBC) and beyond
10个月前
已关闭
皖公网安备34019202002308
